Theravance Bio: 2Q Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Wednesday reported a loss of $39.8 million in its second quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 72 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.
The biopharmaceutical company posted revenue of $26.2 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $13.9 million.
Theravance Bio shares have dropped 22% since the beginning of the year. The stock has dropped 15% in the last 12 months.